NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000056634

Registered date:06/01/2025

Effects of SGLT2 Inhibitors on Diabetic Macular Edema

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedDiabetic Macular Edema
Date of first enrollment2024/10/31
Target sample size1000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeCorrected visual acuity (logMAR conversion) and central retinal thickness by retinal optical coherence tomography in both eyes before and 4, 8, 12, 24, and 48 weeks after the start of SGLT2 inhibitor treatment.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients with iris neovascularization, vitreous hemorrhage, tractional retinal detachment, and active uveitis

Related Information

Contact

public contact
Name Hideyuki Oshima
Address 23-3 Matsuoka-Shimogetsu, Eiheiji-cho, Yoshida-gun, Fukui Prefecture Japan 9101193
Telephone 0776-61-8403
E-mail osm@u-fukui.ac.jp
Affiliation Fukui University Ophthalmology
scientific contact
Name Hideyuki Oshima
Address 23-3 Matsuoka-Shimogetsu, Eiheiji-cho, Yoshida-gun, Fukui Prefecture Japan
Telephone 0776-61-8403
E-mail osm@u-fukui.ac.jp
Affiliation Fukui University Ophthalmology